Skip to main content
. 2021 Jan 25;14(1):1865625. doi: 10.1080/16549716.2020.1865625

Figure 1.

Figure 1.

The WHO generic TB patient cost survey instrument was adapted for use at use at enrollment/start of TB treatment (Day 0) and at Month 2, Month 6, Month 12 and Month 24; time points intended to capture costs incurred for different phases of TB disease (e.g. pre-treatment, on-treatment and post-treatment)